Hiroaki Kanemura Selected Research

1- nitro- 9- (2- dihydroxyethylaminoethylamino)acridine (C 835)

9/2022

Yolk Sac Tumor in a Recurrence of Colonic Adenocarcinoma With Shared Mutations in APC and TP53 Genes: A Case Report.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hiroaki Kanemura Research Topics

Disease

2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 08/2020
2	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2021 - 02/2020
1	Colorectal Neoplasms (Colorectal Cancer) 09/2022
1	Neoplasms (Cancer) 09/2022
1	Squamous Cell Carcinoma of Head and Neck 01/2021
1	Keratitis 01/2021
1	Lung Neoplasms (Lung Cancer) 01/2021
1	Paronychia 01/2021
1	Stomatitis 01/2021
1	Thymoma (Thymic Carcinoma) 03/2020
1	Breast Neoplasms (Breast Cancer) 02/2020
1	Lung Injury 02/2020
1	Hepatitis 01/2020
1	Allergic Rhinitis 03/2019
1	Chest Pain (Chest Pains) 03/2019
1	Fever (Fevers) 03/2019
1	Pleural Effusion (Pleural Effusions) 03/2019
1	Pneumothorax 03/2019
1	Pulmonary Embolism 03/2019
1	Rhinitis 03/2019

Drug/Important Bio-Agent (IBA)

2	Pharmaceutical PreparationsIBA 01/2021 - 02/2020
1	1- nitro- 9- (2- dihydroxyethylaminoethylamino)acridine (C 835)IBA 09/2022
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 09/2022
1	capmatinibIBA 01/2021
1	Cetuximab (Erbitux)FDA Link 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Tyrosine Kinase InhibitorsIBA 01/2021
1	eribulin FDA Link 02/2020
1	Carbon DioxideIBA 03/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 03/2019
1	C-Reactive ProteinIBA 03/2019

Therapy/Procedure

4	Therapeutics 01/2021 - 03/2019
2	Drug Therapy (Chemotherapy) 01/2021 - 03/2020
1	Immunotherapy 01/2021
1	Radiotherapy 03/2020
1	Plasma Exchange 01/2020
1	Gas Lasers 03/2019